The CD4+/CD8+ T cell ratio was notably higher in SSc‐ILD patients compared with SSc‐nonILD patients (1.75 [1.65–2.00] vs 1.11 [0.95–1.54], p < 0.001) (Table 1). This evidence concerns the gene CD4 and systemic sclerosis.